AR and prostate carcinoma: To further explore the molecular mechanism involved in the suppression of AR expression and its signaling in prostate cancer cells mediated by TLX overexpression, we next examined the basal and androgen-stimulated levels of the endogenous AR and PSA in LNCaP-TLX-stable cells.